MariMed Q3 EPS $(0.01) Down From $0.01 YoY, Sales $38.80M Miss $39.60M Estimate
Portfolio Pulse from bharat@benzinga.com
MariMed reported Q3 losses of $(0.01) per share, a 200% decrease YoY. The company's quarterly sales were $38.80M, missing the analyst consensus estimate of $39.60M by 2.02%. However, this is a 14.41% increase over sales of $33.91M the same period last year.
November 08, 2023 | 10:27 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MariMed's Q3 earnings report shows a decrease in earnings and a miss on sales estimates, but an increase in sales compared to last year.
MariMed's Q3 earnings report shows a significant decrease in earnings and a miss on sales estimates, which could negatively impact investor sentiment and the stock price. However, the YoY increase in sales could mitigate some of this negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100